Very few surgeons said they would take a wait-and-watch approach to papillary thyroid cancer, according to a survey-based study.
When 264 thyroid cancer surgeons were asked how they would treat a hypothetical patient with papillary thyroid cancer, about half said they would opt for a thyroid lobectomy while just 1.5% chose active surveillance, reported Megan Haymart, MD, of the University of Michigan in Ann Arbor, and colleagues in JAMA Otolaryngology-Head & Neck Surgery.
